Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520032219> ?p ?o ?g. }
- W1520032219 endingPage "946" @default.
- W1520032219 startingPage "936" @default.
- W1520032219 abstract "The appreciation that the inflammatory reaction does not 'spontaneously' finish, but rather that inflammatory resolution is an active phenomenon brought about by endogenous anti-inflammatory agonists opens multiple opportunities for a reassessment of the complexity of inflammation and its main mediators. This review dwells on one of these pathways, the one centred around the glucocorticoid-regulated protein Annexin A1 and its G protein-coupled receptor. In recent years, much of the knowledge detailing the processes by which Annexin A1 expresses its anti-inflammatory role on innate immunity has been produced. Moreover, the generation of the Annexin A1 null mouse colony has provided important proof-of-concept experiments demonstrating the inhibitory properties of this mediator in the context of inflammatory and/or tissue-injury models. Therefore, Annexin A1 acts as a pivotal homeostatic mediator, where if absent, inflammation would overshoot and be prolonged. This new understanding scientific information could guide us onto the exploitation of the biological properties of Annexin A1 and its receptor to instigate novel drug discovery programmes for anti-inflammatory therapeutics. This line of research relies on the assumption that anti-inflammatory drugs designed upon endogenous anti-inflammatory mediators would be burdened by a lower degree of secondary effects as these agonists would be mimicking specific pathways activated in our body for safe disposal of inflammation. We believe that the next few years will produce examples of such new drugs and the validity of this speculation could then be assessed." @default.
- W1520032219 created "2016-06-24" @default.
- W1520032219 creator A5016097947 @default.
- W1520032219 creator A5061453586 @default.
- W1520032219 date "2009-10-01" @default.
- W1520032219 modified "2023-09-25" @default.
- W1520032219 title "Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics" @default.
- W1520032219 cites W1503364336 @default.
- W1520032219 cites W1510723804 @default.
- W1520032219 cites W1522526317 @default.
- W1520032219 cites W1527314283 @default.
- W1520032219 cites W1538285087 @default.
- W1520032219 cites W1556987023 @default.
- W1520032219 cites W1566207114 @default.
- W1520032219 cites W1577244262 @default.
- W1520032219 cites W1585536154 @default.
- W1520032219 cites W1604280561 @default.
- W1520032219 cites W1613504607 @default.
- W1520032219 cites W1615645448 @default.
- W1520032219 cites W1788924459 @default.
- W1520032219 cites W1794036496 @default.
- W1520032219 cites W1896887853 @default.
- W1520032219 cites W1922367465 @default.
- W1520032219 cites W1932669647 @default.
- W1520032219 cites W1945593336 @default.
- W1520032219 cites W1967803403 @default.
- W1520032219 cites W1968063902 @default.
- W1520032219 cites W1968666896 @default.
- W1520032219 cites W1969049254 @default.
- W1520032219 cites W1971183207 @default.
- W1520032219 cites W1972811309 @default.
- W1520032219 cites W1974392294 @default.
- W1520032219 cites W1980563273 @default.
- W1520032219 cites W1981112866 @default.
- W1520032219 cites W1982283061 @default.
- W1520032219 cites W1984554579 @default.
- W1520032219 cites W1985018359 @default.
- W1520032219 cites W1989197233 @default.
- W1520032219 cites W1991208631 @default.
- W1520032219 cites W1991494867 @default.
- W1520032219 cites W1994389789 @default.
- W1520032219 cites W1995622771 @default.
- W1520032219 cites W1996554934 @default.
- W1520032219 cites W1997347342 @default.
- W1520032219 cites W2000680842 @default.
- W1520032219 cites W2004166313 @default.
- W1520032219 cites W2004536682 @default.
- W1520032219 cites W2008235088 @default.
- W1520032219 cites W2008672256 @default.
- W1520032219 cites W2017218685 @default.
- W1520032219 cites W2018717407 @default.
- W1520032219 cites W2018942052 @default.
- W1520032219 cites W2019833281 @default.
- W1520032219 cites W2021339787 @default.
- W1520032219 cites W2021637137 @default.
- W1520032219 cites W2023702942 @default.
- W1520032219 cites W2025340777 @default.
- W1520032219 cites W2025478043 @default.
- W1520032219 cites W2028952706 @default.
- W1520032219 cites W2032244852 @default.
- W1520032219 cites W2035045924 @default.
- W1520032219 cites W2035809865 @default.
- W1520032219 cites W2036215348 @default.
- W1520032219 cites W2036439732 @default.
- W1520032219 cites W2036816398 @default.
- W1520032219 cites W2037057547 @default.
- W1520032219 cites W2039337732 @default.
- W1520032219 cites W2039341813 @default.
- W1520032219 cites W2042881172 @default.
- W1520032219 cites W2043491417 @default.
- W1520032219 cites W2043731021 @default.
- W1520032219 cites W2044297698 @default.
- W1520032219 cites W2045448610 @default.
- W1520032219 cites W2046445536 @default.
- W1520032219 cites W2048087356 @default.
- W1520032219 cites W2051778349 @default.
- W1520032219 cites W2055210257 @default.
- W1520032219 cites W2056879548 @default.
- W1520032219 cites W2057897974 @default.
- W1520032219 cites W2058583204 @default.
- W1520032219 cites W2064240476 @default.
- W1520032219 cites W2066838089 @default.
- W1520032219 cites W2069186231 @default.
- W1520032219 cites W2069300994 @default.
- W1520032219 cites W2072363531 @default.
- W1520032219 cites W2074618658 @default.
- W1520032219 cites W2076179697 @default.
- W1520032219 cites W2077883691 @default.
- W1520032219 cites W2078690661 @default.
- W1520032219 cites W2079168625 @default.
- W1520032219 cites W2083619020 @default.
- W1520032219 cites W2085292543 @default.
- W1520032219 cites W2088010225 @default.
- W1520032219 cites W2089411255 @default.
- W1520032219 cites W2100607138 @default.
- W1520032219 cites W2101291779 @default.
- W1520032219 cites W2107372340 @default.
- W1520032219 cites W2108095498 @default.